174 related articles for article (PubMed ID: 15963429)
21. Calibration and validation of a quality assurance system for 90Sr/90Y radiation source trains.
Rosenthal P; Weber W; Förster A; Orth O; Köhler B; Seiler F
Phys Med Biol; 2003 Mar; 48(5):573-85. PubMed ID: 12696796
[TBL] [Abstract][Full Text] [Related]
22. Absolute counting of 188Re radiopharmaceuticals.
Yuan MC; Pang HF; Wang CF
Appl Radiat Isot; 2006; 64(10-11):1380-3. PubMed ID: 16556500
[TBL] [Abstract][Full Text] [Related]
23. Resin 90Y microsphere activity measurements for liver brachytherapy.
Dezarn WA; Kennedy AS
Med Phys; 2007 Jun; 34(6):1896-900. PubMed ID: 17654890
[TBL] [Abstract][Full Text] [Related]
24. Yttrium 90 microsphere selective internal radiation treatment of hepatic colorectal metastases.
Gulec SA; Fong Y
Arch Surg; 2007 Jul; 142(7):675-82. PubMed ID: 17638807
[TBL] [Abstract][Full Text] [Related]
25. Standardization of 18F by coincidence and LSC methods.
Roteta M; García-Toraño E; Rodríguez Barquero L
Appl Radiat Isot; 2006; 64(10-11):1199-202. PubMed ID: 16580216
[TBL] [Abstract][Full Text] [Related]
26. Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group.
Salem R; Padia SA; Lam M; Bell J; Chiesa C; Fowers K; Hamilton B; Herman J; Kappadath SC; Leung T; Portelance L; Sze D; Garin E
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1695-1704. PubMed ID: 31098749
[TBL] [Abstract][Full Text] [Related]
27. Experimental determination of the radionuclide calibrator setting for Technesium-99m, by using a primary standardisation method.
Cannatà V; Ciofetta G; Garganese MC; De Felice P; Capogni M; Fazio A; Marracino FM
Nucl Med Commun; 2007 Apr; 28(4):321-6. PubMed ID: 17325597
[TBL] [Abstract][Full Text] [Related]
28. Half-life determination of 88Y and 89Sr.
Amiot MN; Bouchard J; Bé MM; Adamo JA;
Appl Radiat Isot; 2005 Jan; 62(1):11-5. PubMed ID: 15498679
[TBL] [Abstract][Full Text] [Related]
29. Monte Carlo calculations of calibration and geometry correction factors of a radionuclide calibrator.
Olsovcová V; Havelka M
Appl Radiat Isot; 2006; 64(10-11):1370-4. PubMed ID: 16546399
[TBL] [Abstract][Full Text] [Related]
30. A modified method for the characterisation and activity determination of large area sources.
Svec A; Janssen H; Pernická L; Klein R
Appl Radiat Isot; 2006; 64(10-11):1207-10. PubMed ID: 16549354
[TBL] [Abstract][Full Text] [Related]
31. Residual activity after radioembolization of liver tumours with 90Y resin microspheres. A safe calculation method.
Ahmadzadehfar H; Haslerud T; Reichmann K; Meyer C; Habibi E; Fimmers R; Muckle M; Sabet A; Biersack HJ; Ezziddin S
Nuklearmedizin; 2014; 53(3):95-8. PubMed ID: 24105253
[TBL] [Abstract][Full Text] [Related]
32. Precise practical measurements of 90Y used in radiopharmaceuticals using re-entrant ionization chambers.
Yamada T; Ishii K
Appl Radiat Isot; 2012 Sep; 70(9):2246-50. PubMed ID: 22424744
[TBL] [Abstract][Full Text] [Related]
33. Long-lived impurities of 90Y-labeled microspheres, TheraSphere and SIR-spheres, and the impact on patient dose and waste management.
Metyko J; Williford JM; Erwin W; Poston J; Jimenez S
Health Phys; 2012 Nov; 103(5 Suppl 3):S204-8. PubMed ID: 23026974
[TBL] [Abstract][Full Text] [Related]
34. Activity measurements of 18F and 90Y with commercial radionuclide calibrators for nuclear medicine in Switzerland.
Caffari Y; Spring P; Bailat C; Nedjadi Y; Bochud F
Appl Radiat Isot; 2010; 68(7-8):1388-91. PubMed ID: 19954992
[TBL] [Abstract][Full Text] [Related]
35. Positron-emitting resin microspheres as surrogates of 90Y SIR-Spheres: a radiolabeling and stability study.
Avila-Rodriguez MA; Selwyn RG; Hampel JA; Thomadsen BR; Dejesus OT; Converse AK; Nickles RJ
Nucl Med Biol; 2007 Jul; 34(5):585-90. PubMed ID: 17591559
[TBL] [Abstract][Full Text] [Related]
36. Comparison of (90)Y activity measurements in nuclear medicine in Germany.
Kossert K; Bokeloh K; Ehlers M; Nähle O; Scheibe O; Schwarz U; Thieme K
Appl Radiat Isot; 2016 Mar; 109():247-249. PubMed ID: 26597654
[TBL] [Abstract][Full Text] [Related]
37. Clinical and imaging experience with yttrium-90 microspheres in the management of unresectable liver tumours.
Jiao LR; Szyszko T; Al-Nahhas A; Tait P; Canelo R; Stamp G; Wasan H; Lowdell C; Philips R; Thillainayagam A; Bansi D; Rubello D; Limongelli P; Woo K; Habib NA
Eur J Surg Oncol; 2007 Jun; 33(5):597-602. PubMed ID: 17433608
[TBL] [Abstract][Full Text] [Related]
38. Assessment of response to treatment of unresectable liver tumours with 90Y microspheres: value of FDG PET versus computed tomography.
Szyszko T; Al-Nahhas A; Canelo R; Habib N; Jiao L; Wasan H; Pagou M; Tait P
Nucl Med Commun; 2007 Jan; 28(1):15-20. PubMed ID: 17159544
[TBL] [Abstract][Full Text] [Related]
39. Posttherapy radiation safety considerations in radiomicrosphere treatment with 90Y-microspheres.
Gulec SA; Siegel JA
J Nucl Med; 2007 Dec; 48(12):2080-6. PubMed ID: 18006608
[TBL] [Abstract][Full Text] [Related]
40. On uncertainties and errors.
McDonald JC
Radiat Prot Dosimetry; 2004; 111(3):237-8. PubMed ID: 15492066
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
